ALTB-268
Asset
Activates PSGL-1 to downregulate activated T cells and reduce inflammation.
- Stage
- Phase 2
- Modality
- Antibody
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Ulcerative colitis
Phase 2, news.google.com, Oct 20, 2026
In the full profile
- Owner and partners1
- Competitors8
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.